Growth differentiation factor-15 deficiency augments inflammatory response and exacerbates septic heart and renal injury induced by lipopolysaccharide
P Abulizi, N Loganathan, D Zhao, T Mele, Y Zhang… - Scientific reports, 2017 - nature.com
P Abulizi, N Loganathan, D Zhao, T Mele, Y Zhang, T Zwiep, K Liu, X Zheng
Scientific reports, 2017•nature.comSeptic acute kidney injury (AKI) and myocardial dysfunction are leading causes of mortality
with no accepted method of therapy. In this study we demonstrate the role of growth
differentiating factor 15 (GDF15) in septic AKI and myocardial dysfunction using a murine
lipopolysaccharide (LPS)-induced sepsis model and an in vitro cell culture system. Data
show that GDF15 deficiency augments inflammatory response and exacerbates renal and
cardiac injury induced by LPS, while over-expression of GDF15 protects the kidney and …
with no accepted method of therapy. In this study we demonstrate the role of growth
differentiating factor 15 (GDF15) in septic AKI and myocardial dysfunction using a murine
lipopolysaccharide (LPS)-induced sepsis model and an in vitro cell culture system. Data
show that GDF15 deficiency augments inflammatory response and exacerbates renal and
cardiac injury induced by LPS, while over-expression of GDF15 protects the kidney and …
Abstract
Septic acute kidney injury (AKI) and myocardial dysfunction are leading causes of mortality with no accepted method of therapy. In this study we demonstrate the role of growth differentiating factor 15 (GDF15) in septic AKI and myocardial dysfunction using a murine lipopolysaccharide (LPS)-induced sepsis model and an in vitro cell culture system. Data show that GDF15 deficiency augments inflammatory response and exacerbates renal and cardiac injury induced by LPS, while over-expression of GDF15 protects the kidney and heart from LPS-induced organ dysfunction. Therefore, this study highlights the therapeutic potential of GDF15 in the treatment of endotoxin-induced sepsis.
nature.com
